biblio
Export 27 results:
Filters: Author is Nangia, Ashwini [Clear All Filters]
“ Acemetacin cocrystal structures by powder X-ray diffraction”, Iucrj, vol. 4, pp. 206-214, 2017.
, “Cocrystals, salts, and supramolecular gels of nonsteroidal anti inflammatory drug niflumic acid”, Crystal Growth & Design, vol. 19, no. 1, pp. 219-230, 2019.
, “Crystal engineering of a zwitterionic drug to neutral cocrystals: a general solution for floxacins”, Chemical Communications, vol. 52, no. 85, pp. 12610-12613, 2016.
, “Crystal engineering principles: fluoroquinolone salts”, Acta Crystallographica A‐Foundation and Advances, vol. 70, p. C413, 2014.
, “Crystalline acylhydrazone photoswitches with multiple mechanical responses”, Crystal Growth & Design, vol. 19, no. 5, pp. 3039-3044, 2019.
, “Curcumin: pharmaceutical solids as a platform to improve solubility and bioavailability”, Crystengcomm, vol. 20, no. 24, pp. 3277-3296, 2018.
, “Curcumin-artemisinin coamorphous solid: Xenograft model preclinical study”, Pharmaceutics, vol. 10, no. 1, p. Article Number: 7, 2018.
, “Electron crystallography”, IUCRJ, vol. 6, no. 5, pp. 786-787, 2019.
, “Entacapone: improving aqueous solubility, diffusion permeability, and cocrystal stability with theophylline”, Crystal Growth & Design, vol. 18, no. 10, pp. 6061-6069, 2018.
, “Mechanochemical synthesis of N-salicylideneaniline: thermosalient effect of polymorphic crystals”, IUCRJ, vol. 4, pp. 243-250, 2017.
, “ Novel pharmaceutical salts of albendazole”, Crystengcomm, vol. 20, no. 41, pp. 6394-6405, 2018.
, “Pharmaceutical cocrystals: walking the talk”, Chemical Communications, vol. 52, no. 54, pp. 8342-8360, 2016.
, “Pharmaceutical solids in crystal engineering”, Acta Crystallographica A‐Foundation and Advances, vol. 70, p. C12, 2014.
, “Polymorphism, isostructurality and physicochemical properties of glibenclamide salts”, CrystEngComm, vol. 19, no. 6, pp. 918-929, 2017.
, “Quantification of niclosamide polymorphic forms - a comparative study by Raman, NIR and MIR using chemometric techniques”, Talanta, vol. 199, pp. 679-688, 2019.
, “Role of hydrogen bonding in cocrystals and coamorphous solids: indapamide as a case study”, Crystengcomm, vol. 21, no. 13, pp. 2043-2048, 2019.
, “Rufinamide: crystal structure elucidation and solid state characterization”, Journal of Pharmaceutical and Biomedical Analysis, vol. 149, pp. 185-192, 2018.
, “Salts and salt cocrystals of the antibacterial drug pefloxacin”, Crystal Growth & Design, vol. 18, no. 5, pp. 2824-2835, 2018.
, “Separation of a diastereomeric diol pair using the mechanical properties of crystals”, Crystengcomm, vol. 23, no. 40, pp. 7056-7060, 2021.
, “Supramolecular synthon hierarchy in bumetanide cocrystals”, Acta Crystallographica A‐Foundation and Advances, vol. 70, p. C721, 2014.
, “Supramolecular synthon hierarchy in sulfonamide cocrystals with syn-amides and N-oxides”, IUCRJ, vol. 6, pp. 751-760, 2019.
, “Supramolecular synthons in bumetanide cocrystals and ternary products”, Crystal Growth & Design, vol. 17, no. 8, pp. 4225-4236, 2017.
, “Syringic acid: structural elucidation and co-crystallization”, Crystal Growth & Design, vol. 16, no. 8, pp. 4679-4687, 2016.
, “ Systematic synthesis of a 6-component organic-salt alloy of naftopidil, and pentanary, quaternary and ternary multicomponent crystals”, IUCrJ, vol. 5, pp. 816-822, 2018.
, “Thermomechanical effect in molecular crystals: the role of halogen-bonding interactions”, IUCRJ, vol. 4, no. 6, pp. 812-823, 2017.
, “Tracing the architecture of caffeic acid phenethyl ester cocrystals: studies on crystal structure, solubility, and bioavailability implications”, Crystal Growth & Design, vol. 16, no. 10, pp. 5710-5716, 2016.
, “Use of the term "crystal engineering" in the regulatory and patent literature of pharmaceutical solid forms. some comments”, Crystal Growth & Design, vol. 16, no. 10, pp. 5585-5587, 2016.
,